Cargando…

Is there any correlation between spectral CT imaging parameters and PD‐L1 expression of lung adenocarcinoma?

BACKGROUND: The aim of this study was to explore whether spectral computed tomography (CT) imaging parameters are associated with PD‐L1 expression of lung adenocarcinoma. METHODS: Spectral CT imaging parameters (iodine concentrations [IC] of lesion in arterial phase [ICLa] and venous phase [ICLv], n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mai‐Lin, Shi, An‐Hui, Li, Xiao‐ting, Wei, Yi‐Yuan, Qi, Li‐Ping, Sun, Ying‐Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996992/ https://www.ncbi.nlm.nih.gov/pubmed/31808285 http://dx.doi.org/10.1111/1759-7714.13273

Ejemplares similares

Spectral CT imaging parameters and Ki-67 labeling index in lung adenocarcinoma
por: Chen, Mailin, et al.
Publicado: (2020)

Correlation with Spectral CT Imaging Parameters and Occult Lymph Nodes Metastases in Sufferers with Isolated Lung Adenocarcinoma
por: Liu, Ye, et al.
Publicado: (2022)

Prognostic significance of volume-based (18)F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma
por: Wang, Dalong, et al.
Publicado: (2021)

Low-dose spectral CT perfusion imaging of lung cancer quantitative analysis in different pathological subtypes
por: Chen, Mai-Lin, et al.
Publicado: (2021)

Retracted: Correlation with Spectral CT Imaging Parameters and Occult Lymph Nodes Metastases in Sufferers with Isolated Lung Adenocarcinoma
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Spectral CT in the Demonstration of the Pancreatic Arteries and Their Branches: A Comparison With Conventional CT
por: Shi, Yan-Jie, et al.
Publicado: (2016)

PD-L1 in Lung Adenocarcinoma: Insights into the Role of (18)F-FDG PET/CT
por: Cui, Yan, et al.
Publicado: (2020)

Utility of CT radiomics for prediction of PD‐L1 expression in advanced lung adenocarcinomas
por: Yoon, Jiyoung, et al.
Publicado: (2020)

PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
por: Wu, Xiaodong, et al.
Publicado: (2020)

Application Value of Spectral CT Imaging in Quantitative Analysis of Early Lung Adenocarcinoma
por: Du, Wang, et al.
Publicado: (2022)

Initial experience of correlating diffusion spectral parameters with histopathologic indexes in murine colorectal tumor homografts
por: Zhang, Xiao-Yan, et al.
Publicado: (2017)

Correlation between PD-L1 expression and radiomic features in early-stage lung adenocarcinomas manifesting as ground-glass nodules
por: Shi, Wenjia, et al.
Publicado: (2022)

Can PD-L1 expression be predicted by contrast-enhanced CT in patients with gastric adenocarcinoma? a preliminary retrospective study
por: Gu, Xiaolong, et al.
Publicado: (2022)

Preliminary application of multiple parameters spectral CT in the diagnosis of ovarian cancer
por: Pang, Tao, et al.
Publicado: (2017)

Differential diagnosis of adrenal adenomas and metastases using spectral parameters in dual-layer detector spectral CT
por: Wu, Lei-di, et al.
Publicado: (2023)

The value of dual-energy spectral CT in differentiating solitary pulmonary tuberculosis and solitary lung adenocarcinoma
por: Zhang, Guojin, et al.
Publicado: (2022)

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression
por: Cai, Yiran, et al.
Publicado: (2020)

Expression of AKT and p-AKT protein in lung adenocarcinoma and its correlation with PD-L1 protein and prognosis
por: Hu, Zhi-Ying, et al.
Publicado: (2020)

Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
por: Koh, Young Wha, et al.
Publicado: (2023)

CT-pathologic correlation in lung adenocarcinoma and squamous cell carcinoma
por: Yue, Jun-Yan, et al.
Publicado: (2018)

TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma
por: Zhong, Anyuan, et al.
Publicado: (2021)

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma
por: Guo, Chang-Ying, et al.
Publicado: (2019)

Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
por: Li, Kang, et al.
Publicado: (2022)

Diagnostic value of dual-layer spectral detector CT in differentiating lung adenocarcinoma from squamous cell carcinoma
por: Mu, Ronghua, et al.
Publicado: (2022)

Synchronous ground‐glass nodules showed limited response to anti‐PD‐1/PD‐L1 therapy in patients with advanced lung adenocarcinoma
por: Wu, Fengying, et al.
Publicado: (2020)

The predictive value of energy spectral CT parameters for assessing Ki-67 expression of lung cancer
por: Dou, Peipei, et al.
Publicado: (2020)

Dual-layer spectral detector computed tomography parameters can improve diagnostic efficiency of lung adenocarcinoma grading
por: Mu, Ronghua, et al.
Publicado: (2022)

MicroRNA‐155‐5p suppresses PD‐L1 expression in lung adenocarcinoma
por: Huang, Jiansheng, et al.
Publicado: (2020)

Correlation of pulmonary venous circulating tumor cells with clinicopathological parameters in patients with early-stage lung adenocarcinoma
por: Xu, Shi-Bin, et al.
Publicado: (2019)

Correlation between PD-L1 expression (clones 28-8 and SP263) and histopathology in lung adenocarcinoma
por: García, Alejandro, et al.
Publicado: (2020)

AIM2 upregulation promotes metastatic progression and PD‐L1 expression in lung adenocarcinoma
por: Zheng, Jing‐Quan, et al.
Publicado: (2022)

CT imaging indications correlate with the degree of lung adenocarcinoma infiltration
por: He, Wenchen, et al.
Publicado: (2023)

CT Radiomics Combined With Clinicopathological Features to Predict Invasive Mucinous Adenocarcinoma in Patients With Lung Adenocarcinoma
por: Zhang, Junjie, et al.
Publicado: (2023)

PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung
por: Janzic, Urska, et al.
Publicado: (2017)

CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers
por: Gao, Feng, et al.
Publicado: (2019)

Clinical importance of VEGFC and PD‐L1 co‐expression in lung adenocarcinoma patients
por: Qin, Tingting, et al.
Publicado: (2020)

Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
por: Ma, Ke, et al.
Publicado: (2020)

Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma
por: Fan, Linwei, et al.
Publicado: (2020)

The value of combined PET/MRI, CT and clinical metabolic parameters in differentiating lung adenocarcinoma from squamous cell carcinoma
por: Tang, Xin, et al.
Publicado: (2022)

CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kq01afl01m992hags012gcqtb0